2'-Deoxythymidine Adducts from the Anti-HIV Drug Nevirapine
Nevirapine (NVP) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used against HIV-1. Currently, NVP is the most widely used anti-HIV drug in developing countries, both in combination therapy and to prevent mother-to-child transmission of HIV. Despite its efficacy against HIV, NVP produce...
Main Authors: | M. Matilde Marques, Frederick A. Beland, M. Conceição Oliveira, Benjamin Wolf, Alexandra M. M. Antunes |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2013-04-01
|
Series: | Molecules |
Subjects: | |
Online Access: | http://www.mdpi.com/1420-3049/18/5/4955 |
Similar Items
-
Covalent Histone Modification by an Electrophilic Derivative of the Anti-HIV Drug Nevirapine
by: Shrika G. Harjivan, et al.
Published: (2021-03-01) -
Global Conformational Dynamics of HIV-1 Reverse Transcriptase Bound to Non-Nucleoside Inhibitors
by: Peter V. Coveney, et al.
Published: (2012-07-01) -
Revisiting efavirenz in the era of dolutegravir: Low-dose efavirenz, a viable alternative capable of holding its own against dolutegravir-based regimens
by: Sumit Arora, et al.
Published: (2023-01-01) -
Delay of cell growth and loss of stemness by inhibition of reverse transcription in human mesenchymal stem cells derived from dental tissue
by: Won-Cheol Lee, et al.
Published: (2019-09-01) -
Me-Better Drug Design Based on Nevirapine and Mechanism of Molecular Interactions with Y188C Mutant HIV-1 Reverse Transcriptase
by: Yan Wang, et al.
Published: (2022-10-01)